DNMT1 and periodontal disorder: Conversely, the detrimental effects of DNMT inhibitors on GF and PDLF proliferation and viability, as well as the activation of multiple pro-inflammatory pathways associated with the pathobiology of periodontal disease, may greatly limit the therapeutic potential of these compounds.